Global Trust Asset Management LLC Sells 5,915 Shares of Danaher Corporation $DHR

Global Trust Asset Management LLC cut its stake in Danaher Corporation (NYSE:DHR) by 91.2% in the 1st quarter, Holdings Channel.com reports. The fund owned 570 shares of the conglomerate’s stock after selling 5,915 shares during the quarter. Global Trust Asset Management LLC’s holdings in Danaher were worth $108,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of DHR. JPL Wealth Management LLC bought a new stake in Danaher during the third quarter worth about $25,000. Elevated Capital Advisors LLC acquired a new position in shares of Danaher in the 4th quarter valued at approximately $26,000. WFA of San Diego LLC acquired a new position in shares of Danaher in the 2nd quarter valued at approximately $26,000. Hilton Head Capital Partners LLC bought a new stake in shares of Danaher during the 4th quarter worth approximately $27,000. Finally, Clal Insurance Enterprises Holdings Ltd boosted its position in shares of Danaher by 71.6% during the 4th quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock worth $29,000 after acquiring an additional 53 shares in the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several brokerages have commented on DHR. DZ Bank began coverage on shares of Danaher in a research report on Wednesday, June 3rd. They set a “buy” rating and a $210.00 price objective for the company. Morgan Stanley decreased their price target on Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd. TD Cowen lowered their price target on Danaher from $245.00 to $240.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. Royal Bank Of Canada assumed coverage on Danaher in a research note on Thursday, May 14th. They issued an “outperform” rating and a $200.00 price objective on the stock. Finally, Evercore lifted their target price on Danaher from $225.00 to $232.00 and gave the company an “outperform” rating in a research report on Tuesday, April 21st. One research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $233.61.

Danaher Stock Performance

NYSE:DHR opened at $190.26 on Wednesday. The stock’s 50-day moving average is $178.72 and its 200-day moving average is $201.03. The stock has a market cap of $134.66 billion, a P/E ratio of 36.80, a price-to-earnings-growth ratio of 2.46 and a beta of 0.81. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last posted its earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. The firm had revenue of $5.95 billion for the quarter, compared to analyst estimates of $6 billion. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The company’s revenue for the quarter was up 3.7% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.88 EPS. Equities research analysts anticipate that Danaher Corporation will post 8.44 earnings per share for the current year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be given a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Friday, June 26th. Danaher’s payout ratio is 30.95%.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.